Dr Deogratias Munube
Dr. Deogratias Munube (MBCHB, MMED, PhD [C])
Deogratias is a Consultant Pediatrician, Honorary Lecturer and PhD candidate in the Department of Paediatrics and Child Health, Mulago Hospital/ Makerere University Kampala. He is the Assistant Clinical head in the Directorate, Coordinator MMED Haematology Oncology Course and Coordinator MBCHB V course. He has had 10 years of experience in neonatal and child health (5 years up-country and 5 years in an urban setting).
He is an ETAT+ trainer (Emergency Triage Assessment and Treatment in the first 24 hrs) and has participated in the introduction of ETAT+ in Uganda with the support of the Department of Paediatrics and Child Health, Makerere University/Ministry of Health, Uganda and in partnership with the Royal College of Paediatrics and Child Health, UK. Over the last 5 years, he has been involved in care, treatment and research in children with sickle cell disease. Munube has completed sub-speciality training in Paediatric Haematology and Oncology at Uganda Cancer Institute and Mulago National Referral Hospital Kampala. His PhD in neurology is on stroke in children with sickle cell anaemia. The program is part of the larger MEPI-Neuro-linked NIH support for developing leaders in neurology in Uganda.
Publications in 2019/2020
|1.||Paediatric immunisation and chemoprophylaxis in a Ugandan sickle cell disease clinic. Chen CJ, Bakeera-Kitaka S, Mupere E, Kasirye P, Munube D, Idro R, Hume H, Pfeffer B, aRussa P, Green NS.J Paediatr Child Health. 2019 Jul;55(7):795-801. doi:10.1111/jpc.14291. Epub 2018 Nov 9.PMID: 30411430|
|2.||Burden of neurological and neurocognitive impairment in pediatric sickle cell anemia in Uganda (BRAIN SAFE): a cross-sectional study. Green NS, Munube D, Bangirana P, Buluma LR, Kebirungi B, Opoka R, Mupere E, Kasirye P, Kiguli S, Birabwa A, Kawooya MS, Lubowa SK, Sekibira R, Kayongo E, Hume H, Elkind M, Peng W, Li G, Rosano C, LaRussa P, Minja FJ, Boehme A, Idro R.BMC Pediatr. 2019 Oct 25;19(1):381. doi: 10.1186/s12887-019-1758-2.PMID: 31651270|
|3.||The Sickle Cell Disease Ontology: Enabling Collaborative Research and Co-Designing of New Planetary Health Applications. Nembaware V, Mazandu GK, Hotchkiss J, Safari Serufuri JM, Kent J, Kengne AP, Anie K, Munung NS, Bukini D, Bitoungui VJN, Munube D, Chirwa U, Chunda-Liyoka C, Jonathan A, Flor-Park MV, Esoh KK, Jonas M, Mnika K, Oosterwyk C, Masamu U, Morrice J, Uwineza A, Nguweneza A, Banda K, Nyanor I, Adjei DN, Siebu NE, Nkanyemka M, Kuona P, Tayo BO, Campbell A, Oron AP, Nnodu OE, Painstil V, Makani J, Mulder N, Wonkam A.OMICS. 2020 Oct;24(10):559-567. doi: 10.1089/omi.2020.0153.PMID: 33021900|
|4.||Health-related quality of life of adolescents with sickle cell disease in sub-Saharan Africa: a cross-sectional study.Kambasu DM, Rujumba J, Lekuya HM, Munube D, Mupere E.BMC Hematol. 2019 May 14;19:9. doi: 10.1186/s12878-019-0141-8. eCollection 2019.PMID: 31114692|
|5.||The Sickle Cell Disease Ontology: enabling universal sickle cell-based knowledgerepresentation.Sickle Cell Disease Ontology Working Group.Database (Oxford). 2019 Jan 1;2019:baz118. doi: 10.1093/database/baz118.PMID: 31769834|
|6.||Barriers to effective uptake and provision of immunization in a rural district in Uganda. Malande OO, Munube D, Afaayo RN, Annet K, Bodo B, Bakainaga A, Ayebare E, Njunwamukama S, Mworozi EA, Musyoki AM.PLoS One. 2019 Feb 14;14(2):e0212270. doi: 10.1371/journal.pone.0212270. eCollection 2019.PMID: 30763355|
|7.||Extending the measurement of quality beyond service delivery indicators. Agweyu A, Masenge T, Munube D.BMJ Glob Health. 2020 Dec;5(12):e004553. doi: 10.1136/bmjgh-2020-004553.PMID: 33355260|